We are pleased to share with you the exciting news that Medasense has received AMAR approval to sell our pain (Nociception) monitoring system in Israel! Israeli anesthesiologists are now able to join their European colleagues, who are already using our technology
Medasense featured in Innovations in Pharmaceutical Technology publication. Read our article written by CEO, Galit Zuckerman-Stark, to learn how an objective approach could help healthcare professionals better assess pain. To read the full article click here. The article is taken from Innovations in Pharmaceutical
Medasense featured as one of 106 Artificial Intelligence (AI) Startups In Healthcare by CB Insights website, under the Emergency Room & Surgery section.
Read the publication regarding the PMD-200™ pain monitoring device here (in Italian).